Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency

Abstract We evaluated the diagnostic accuracy of insulin-like growth factor-1 (IGF-1) for screening growth hormone deficiency (GHD) to determine the usefulness of IGF-1 as a screening test. Among 298 consecutive children who had short stature or decreased height velocity, we measured IGF-1 levels an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hideyuki Iwayama, Sachiko Kitagawa, Jyun Sada, Ryosuke Miyamoto, Tomohito Hayakawa, Yoshiyuki Kuroyanagi, Taichiro Muto, Hirokazu Kurahashi, Wataru Ohashi, Junko Takagi, Akihisa Okumura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/da4542514cd044afa232c54bf41aeb47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da4542514cd044afa232c54bf41aeb47
record_format dspace
spelling oai:doaj.org-article:da4542514cd044afa232c54bf41aeb472021-12-02T16:27:45ZInsulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency10.1038/s41598-021-95632-02045-2322https://doaj.org/article/da4542514cd044afa232c54bf41aeb472021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95632-0https://doaj.org/toc/2045-2322Abstract We evaluated the diagnostic accuracy of insulin-like growth factor-1 (IGF-1) for screening growth hormone deficiency (GHD) to determine the usefulness of IGF-1 as a screening test. Among 298 consecutive children who had short stature or decreased height velocity, we measured IGF-1 levels and performed growth hormone (GH) secretion test using clonidine, arginine, and, in cases with different results of the two tests, L-dopa. Patients with congenital abnormalities were excluded. GHD was defined as peak GH ≤ 6.0 ng/mL in the two tests. We identified 60 and 238 patients with and without GHD, respectively. The mean IGF-1 standard deviation (SD) was not significantly different between the GHD and non-GHD groups (p = 0.23). Receiver operating characteristic curve analysis demonstrated the best diagnostic accuracy at an IGF-1 cutoff of − 1.493 SD, with 0.685 sensitivity, 0.417 specificity, 0.25 positive and 0.823 negative predictive values, and 0.517 area under the curve. Correlation analysis revealed that none of the items of patients’ characteristics increased the diagnostic power of IGF-1. IGF-1 level had poor diagnostic accuracy as a screening test for GHD. Therefore, IGF-1 should not be used alone for GHD screening. A predictive biomarker for GHD should be developed in the future.Hideyuki IwayamaSachiko KitagawaJyun SadaRyosuke MiyamotoTomohito HayakawaYoshiyuki KuroyanagiTaichiro MutoHirokazu KurahashiWataru OhashiJunko TakagiAkihisa OkumuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hideyuki Iwayama
Sachiko Kitagawa
Jyun Sada
Ryosuke Miyamoto
Tomohito Hayakawa
Yoshiyuki Kuroyanagi
Taichiro Muto
Hirokazu Kurahashi
Wataru Ohashi
Junko Takagi
Akihisa Okumura
Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
description Abstract We evaluated the diagnostic accuracy of insulin-like growth factor-1 (IGF-1) for screening growth hormone deficiency (GHD) to determine the usefulness of IGF-1 as a screening test. Among 298 consecutive children who had short stature or decreased height velocity, we measured IGF-1 levels and performed growth hormone (GH) secretion test using clonidine, arginine, and, in cases with different results of the two tests, L-dopa. Patients with congenital abnormalities were excluded. GHD was defined as peak GH ≤ 6.0 ng/mL in the two tests. We identified 60 and 238 patients with and without GHD, respectively. The mean IGF-1 standard deviation (SD) was not significantly different between the GHD and non-GHD groups (p = 0.23). Receiver operating characteristic curve analysis demonstrated the best diagnostic accuracy at an IGF-1 cutoff of − 1.493 SD, with 0.685 sensitivity, 0.417 specificity, 0.25 positive and 0.823 negative predictive values, and 0.517 area under the curve. Correlation analysis revealed that none of the items of patients’ characteristics increased the diagnostic power of IGF-1. IGF-1 level had poor diagnostic accuracy as a screening test for GHD. Therefore, IGF-1 should not be used alone for GHD screening. A predictive biomarker for GHD should be developed in the future.
format article
author Hideyuki Iwayama
Sachiko Kitagawa
Jyun Sada
Ryosuke Miyamoto
Tomohito Hayakawa
Yoshiyuki Kuroyanagi
Taichiro Muto
Hirokazu Kurahashi
Wataru Ohashi
Junko Takagi
Akihisa Okumura
author_facet Hideyuki Iwayama
Sachiko Kitagawa
Jyun Sada
Ryosuke Miyamoto
Tomohito Hayakawa
Yoshiyuki Kuroyanagi
Taichiro Muto
Hirokazu Kurahashi
Wataru Ohashi
Junko Takagi
Akihisa Okumura
author_sort Hideyuki Iwayama
title Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
title_short Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
title_full Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
title_fullStr Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
title_full_unstemmed Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
title_sort insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/da4542514cd044afa232c54bf41aeb47
work_keys_str_mv AT hideyukiiwayama insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT sachikokitagawa insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT jyunsada insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT ryosukemiyamoto insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT tomohitohayakawa insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT yoshiyukikuroyanagi insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT taichiromuto insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT hirokazukurahashi insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT wataruohashi insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT junkotakagi insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
AT akihisaokumura insulinlikegrowthfactor1levelisapoordiagnosticindicatorofgrowthhormonedeficiency
_version_ 1718384020896612352